Semaglutide - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen
AUST R: 446290
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

From
01 Jun 2025
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
This product replaces ARTG 308324 OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen which has been discontinued. More information about this supply change is available from https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/new-presentation-ozempic-semaglutide-025-mg05-mg-pre-filled-pens. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd, can be contacted for details on supply on 1300 788 261.
OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen
AUST R: 315107
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

From
15 Apr 2022
to
31 Dec 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd, can be contacted for details on supply on 1300 788 261. A TGA web statement is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/update-ozempic-supply-remain-limited-2025.
OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen
AUST R: 308324
Active ingredients:
Semaglutide

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800668626

Deletion from market:
01 Dec 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
This product will be replaced by ARTG 446290 OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen. More information about this supply change is available from https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/new-presentation-ozempic-semaglutide-025-mg05-mg-pre-filled-pens. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd, can be contacted for details on supply on 1300 788 261.